Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Abbott a Step Closer to FACT
Yahoo/Zacks
Saturday, April 10, 2010 - 12:10pm
tags:
Abbott Laboratories, Facet Biotech, daclizumab, multiple sclerosis, Biogen Idec
Breast Cancer Drug T-DM1 Expected To Deliver Exciting Data In First Half Of 2010; Roche Expected To File For NDA
Yahoo/Wall St. Transcript
Saturday, April 10, 2010 - 11:44am
tags:
T-DM1, Roche, breast cancer
Cell's Pixantrone Denied Approval
Yahoo/Zacks
Saturday, April 10, 2010 - 11:41am
tags:
Cell Therapeutics, Pixuvri, non-Hodgkin's lymphoma
Celgene (CELG) Is A Top-Growth Biotech Stock; High P/E Multiple And Global Expansion Of Its Myeloma Franchise And REVLIMID Makes It A Top Stock Pick
Yahoo/Wall St. Transcript
Saturday, April 10, 2010 - 11:39am
tags:
Celgene, Revlimid, Multiple Myeloma
Roche Aims to Expand Rituxan Label
Yahoo/Zacks
Saturday, April 10, 2010 - 11:37am
tags:
Roche, Rituxan, PRIMA, follicular lymphoma
SciClone rallies on upgrade; drug indices diverge
Marketwatch
Friday, April 9, 2010 - 11:33am
tags:
SciClone, drug stocks
Cephalon finishes acquisition of drugmaker Mepha
Businessweek
Friday, April 9, 2010 - 11:32am
tags:
Mepha, Cephalon, M&A
Johnson & Johnson (NYSE: JNJ): First Quarter 2010 Earnings Preview
iStockAnalyst
Friday, April 9, 2010 - 11:30am
tags:
earnings, JNJ
Sanofi opens R&D center in China
Fierce Biotech
Friday, April 9, 2010 - 11:28am
tags:
R&D, China, Sanofi
Lawyer for female Novartis workers says they are cheated but company denies claim in NYC trial
SF Examiner, CA
Friday, April 9, 2010 - 11:28am
tags:
Novartis, discrimination
Celgene says stem cell therapy met safety goal
Yahoo/AP
Friday, April 9, 2010 - 11:27am
tags:
Celgene, stem cells, Crohn's Disease
Boston Scientific Mulls Sale of Two Units
TheStreet.com
Friday, April 9, 2010 - 11:25am
tags:
M&A, Boston Scientific, Abbott Laboratories, JNJ
Cell Therapeutics Closer to the Brink
TheStreet.com
Friday, April 9, 2010 - 7:56am
tags:
Cell Therapeutics, pixantrone
Study: St. Jude, Medtronic could benefit from Boston Sci woes
Fierce Medical Devices
Friday, April 9, 2010 - 7:55am
tags:
Boston Scientific, St. Jude Medical, Medtronic, defibrillators
Merck KGaA’s $6 Billion Millipore Deal ’Worth Every Euro’
Bloomberg
Friday, April 9, 2010 - 7:53am
tags:
Merck KGaA, M&A, Millipore
Biogen Races to Create Test for Brain Disease Linked to MS Drug
Bloomberg
Friday, April 9, 2010 - 7:52am
tags:
Biogen Idec, Tysabri, MS, multiple sclerosis, PML
King Advances Pain Candidate
Yahoo/Zacks.com
Friday, April 9, 2010 - 7:51am
tags:
King, Durect Corporation, painkillers, Eladur, Pain Therapeutics
Novartis aware of gender discrimination for years, lawyer says
NY Post, NY
Thursday, April 8, 2010 - 5:53pm
tags:
discrimination, Novartis, lawsuits
Good News for MDRNA
Yahoo/Zacks.com
Thursday, April 8, 2010 - 5:51pm
tags:
MDRNA, Cequent Pharmaceuticals, M&A
FDA recruits consumer reps for advisory panels
Fierce Pharma
Thursday, April 8, 2010 - 2:28pm
tags:
FDA, advisory panels

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.